Tag: NASDAQ:VYNE

VYNE has 36-month beta value of 1.28. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,”

Company’s 36-month beta value is 1.25.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as

Additionally, the 36-month beta value for VYNE is 1.20. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0